Machine learning of molecular dynamics simulations provides insights into modulation of viral capsid assembly
Ànna PavlovaiD, Zixing FaniD, Diane L. LynchiD, James C. GumbartiD
Abstract
An effective approach in the development of novel antivirals is to target the assembly of viral capsids using capsid assembly modulators (CAMs). CAMs targeting hepatitis B virus (HBV) have two major modes of function: they can either accelerate nucleocapsid assembly, retaining its structure, or misdirect it into non-capsid-like particles. Previous molecular dynamics (MD) simulations of early capsid-assembly intermediates showed differences in protein conformations for apo and bound states. Here, we have developed and tested several classification machine learning (ML) models to better distinguish between apo-tetramer intermediates and those bound to accelerating or misdirecting CAMs. Models based on tertiary structural properties of the Cp149 tetramers and their inter-dimer orientation, as well as models based on direct and inverse contact distances between protein residues, were tested. All models distinguished the apo states and the two CAM-bound states with high accuracy. Furthermore, tertiary structure models and residue-distance models highlighted different tetramer regions as important for classification. Both models can be used to better understand structural transitions that govern the assembly of nucleocapsids and to assist the development of more potent CAMs. Finally, we demonstrate the utility of classification ML methods in comparing MD trajectories and describe our ML approaches, which can be extended to other systems of interest. TOC Graphic O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=111 SRC="FIGDIR/small/637202v1_ufig1.gif" ALT="Figure 1"> View larger version (17K): org.highwire.dtl.DTLVardef@b2a910org.highwire.dtl.DTLVardef@1798a02org.highwire.dtl.DTLVardef@539b80org.highwire.dtl.DTLVardef@105f0aa_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 10
- FWCI
- 2.98
- Field percentile
- top 8%
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mechanism of action of HBV capsid assembly modulators predicted from binding to early assembly intermediates
Anna Pavlova, Leda Bassit, … James C. Gumbart·bioRxiv·Mar 23, 2020
- Modeling Reveals How Direct-Acting Antivirals Redirect HBV Capsid Assembly Pathways to Noninfectious Products
Layne B. Frechette, Smriti Pradhan, … Michael F. Hagan·bioRxiv·May 26, 2026
- Mechanistic insights into CAM-induced disruption of HBV capsids revealed by all-atom MD simulations
Carolina Pérez-Segura, Boon Chong Goh, Jodi A. Hadden‐Perilla·PLoS PathogensPeer-reviewed·Feb 9, 2026
- Molecular elucidation of drug-induced abnormal assemblies of the Hepatitis B Virus capsid protein by solid-state NMR
L. Lecoq, L. Brigandat, … A. Bockmann·bioRxiv·Sep 14, 2022
- Assembly-active and -inactive forms of HBV capsid protein provide distinctly different binding sites for capsid assembly modulators
Liam W. Scott, Carolina Pérez-Segura, … Adam Zlotnick·bioRxiv·May 14, 2026
- Multiscale Modeling of Hepatitis B Virus Capsid Assembly and its Dimorphism
F. Mohajerani, B. Tyukodi, … M. F. Hagan·bioRxiv·Feb 23, 2022